| 3.56 -0.12 (-3.26%) | 12-17 16:00 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | |
|||
| Targets | 6-month : | 1-year : | ||
| Resists | First : | Second : | ||
| Pivot price | ||||
| Supports | First : | Second : | ||
| MAs | MA(5) : | MA(20) : | ||
| MA(100) : | MA(250) : | |||
| MACD | MACD : | Signal : | ||
| %K %D | K(14,3) : | D(3) : | ||
| RSI | RSI(14): | |||
| 52-week | High : | Low : | ||
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
Performant Financial Corporation, a U.S.-based company headquartered in Livermore, California, provides technology-driven services encompassing auditing, debt recovery, customer outsourcing, and related analytical support. Established in 1976 as DCS Holdings, Inc., the firm adopted its current name in 2005. The company specializes in various recovery services. For instance, it assists both federal guaranteed student loan programs and private institutions by identifying and monitoring defaulted borrowers within their loan portfolios, ultimately facilitating the rehabilitation and collection of overdue student loans. Performant also handles tax recovery for federal, state, and municipal agencies, and manages general government debt collection for a range of federal bodies. In the healthcare sector, Performant offers critical audit and recovery solutions to public and private clients. These services aim to uncover inappropriate payments caused by issues such as incorrect medical coding, procedures deemed not medically necessary, incomplete patient documentation, or claims processed using outdated fee schedules. Beyond recovery, the company extends its offerings to include first-party call center operations and other outsourced support services. A significant part of its portfolio is "Performant Insight," a specialized platform delivering comprehensive solutions like pre- and post-payment audits of healthcare claims, advanced detection of fraud, waste, and abuse in the healthcare system, coordination of benefits, and targeted pharmacy fraud detection services.
Fri, 02 Oct 2026
Performant Financial runs payment audits: what it means for Performant Financial stock - AD HOC NEWS
Tue, 10 Dec 2024
Performant Announces Name Change to Performant Healthcare, Inc. – Concludes Strategic Shift to Healthcare - Business Wire
Tue, 12 Nov 2024
Performant Financial to Present Growth Strategy at Craig-Hallum Conference - stocktitan.net
Fri, 06 Sep 2024
Performant Financial Corporation Announces Multi-Year RAC Award from New York State - 01net.it
Tue, 09 Apr 2024
Performant Financial Corporation Acquires Artificial Intelligence Technology in Support of Its Scale Initatives - Business Wire
Tue, 09 May 2023
Performant Financial Corporation Announces Executive Leadership Transitions - Business Wire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Industrials
|
|
|
Industry:
Specialty Business Services
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | (%) |
| Held by Institutions | (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | |
| EPS Est Next Qtrly | |
| EPS Est This Year | |
| EPS Est Next Year | |
| Book Value (p.s.) | |
| Profit Margin | % |
| Operating Margin | % |
| Return on Assets (ttm) | % |
| Return on Equity (ttm) | % |
| Qtrly Rev. Growth | % |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | |
| Price to Cash Flow |
| Dividend | |
| Forward Dividend | |
| Dividend Yield | 0% |
| Dividend Pay Date | |
| Ex-Dividend Date |